Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 37 EP890 | DOI: 10.1530/endoabs.37.EP890

ECE2015 Eposter Presentations Thyroid cancer (90 abstracts)

Sentinel lymph node biopsy in medullary thyroid carcinoma: a pilot study

Radan Dzodic 1, , Nada Santrac 2 , Merima Oruci 2 , Ivan Markovic 1, , Igor Djurisic 2 , Marko Buta 2 & Gordana Pupic 3


1Medical School, University of Belgrade, Belgrade, Serbia; 2Surgical Oncology Clinic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; 3Department of Pathology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.


Introduction: Serum calcitonin levels (sCT) in medullary thyroid carcinoma (MTC) correlate with the tumour size and disease progression. Lymph node (LN) metastases can be verified even in sCT lower than 100 pg/ml. The extent of LN dissection has not yet been standardised. The aim of this pilot study was to show our experience with sentinel lymph node (SLN) biopsy of jugulo-carotid chain (JCC) in selection of patients with MTC for modified radical neck dissection (MRND).

Materials and methods: Following protocols of our institution, all patients with confirmed thyroid carcinoma on intraoperative frozen section analysis undergo total thyroidectomy, central neck dissection, and SLN biopsy of JCC. SLN biopsy is performed after peritumoral injection of 1%-methylene blue dye (0.2–0.5 ml), and frozen section examination follows, in order to make decision on further MRND. For this study, we have selected 13 patients treated surgically from year 2007 to 2015 due to suspect MTC with increase of sCT, clinically and ultrasonically verified thyroid tumour and ‘clear’ regional lymph nodes. Inclusion criteria for this pilot study were sCT lower than 1000 pg/ml and subcentimetre tumour size. All patients had uni- or bilateral SLN biopsy of supraomohyoid regions (II–III). Besides these blue stained SLNs, we have removed surrounding LNs of II and III region in order to obtain more precise definite pathological evaluation of LNs.

Results: In dissected central LNs, metastases were not verified. All SLNs were identified as benign, both on frozen section and definite pathological analysis, thus there were no false negative results. Besides SLNs, all LNs extirpated from II to III regions were benign on definite pathology reports. On postoperative check-ups, all sCT were in the normal range, patients suffered no complications of thyroid surgery and none have disease relapses. The SLN biopsy method’s accuracy is 100%.

Conclusion: This pilot study is the first reported experience with SLN biopsy of JCC in MTC using methylene blue dye. SLN biopsy can be precisely used for intraoperative assessment of lateral neck compartment. It enables adequate surgery for patients with subcentimetre MTC and sCT under 1000 pg/ml, avoiding unnecessary prophylactic MRND.

Article tools

My recent searches

No recent searches.